In this special, 2-part premiere episode, Drs. Sahil Parikh and Erin Murphy share their experiences as they explore new technologies and strategies for vascular imaging in patients with peripheral vascular disease.
Part I: Focus on Physiology and Imaging in Arterial Intervention
Join Sahil A. Parikh, MD for an in-depth evaluation of novel approaches to diagnostics in arterial interventions. Focusing on enhancing your understanding of human physiology and best practices for imaging interpretation, Dr. Parikh reviews the evolution of imaging technologies, highlighting the advantages that have rendered intravascular ultrasound the dominant modality in our field. Through analysis of challenging, real-world cases, you’ll learn how to utilize invasive hemodynamics and intravascular ultrasound to optimally assess, prepare, and treat your patients with peripheral vascular disease, while also reducing risks, setting the stage for improved outcomes.
Part II: Focus on Deep Venous Interventions
In Part II of this episode, Erin H. Murphy, MD takes us on an in-depth look at novel approaches to diagnostic imaging in deep venous interventions. Dr. Murphy shares her stepwise and individualized approach to the identification, diagnosis, and treatment of peripheral vascular disease, focusing on utilizing the appropriate imaging tools before, during, and post-procedure. Learn how vascular imaging is both an art and a science as Dr. Murphy reviews clinical data, provides useful tips and techniques, and revisits illustrative cases that can help you provide optimal management for your patients with peripheral vascular disease.
After completing this activity, the participant should be better able to:
- Describe the limitations of using angiography alone for vascular imaging
- Explain how imaging selection between invasive hemodynamics, venogram and/or IVUS can impact patient outcomes
- Interpret IVUS imaging to determine appropriate next steps in therapy
- Define the role of ultrasound in procedure planning for patients requiring deep venous stenting and follow-up of patients post operatively
The educational design of this activity addresses the needs of Interventional Radiologists, Vascular Surgeons, Vascular Specialists, Nurse Practitioners, Radiologic Technologists, and Vascular Allied Health Professionals involved in the treatment of patients with peripheral vascular disease.
Erin H. Murphy, MD, FACS
Venous & Lymphatic Institute
Sanger Heart & Vascular Institute
Charlotte, NC, USA
Dr. Erin H. Murphy is a vascular surgeon with the Sanger Heart and Vascular Institute at Atrium Health in Charlotte, NC, where she serves as the Director of the Venous and Lymphatic Program. She specializes in the treatment of pelvic and lower extremity venous disorders.
Dr. Murphy is dedicated to both her patients as well as the advancement of the venous field. She has extensive research experience and has authored over 50 medical journal articles, book chapters and editorials. She presents routinely at both national and international conferences. She is currently participating in several major venous trials and is the US principal investigator for the Medtronic ABRE stent trial.
Sahil A. Parikh, MD, FACC, FSCAI
Associate Professor of Medicine, Columbia University
Vagelos College of Physicians and Surgeons
Director of Endovascular Services
NY Presbyterian/Columbia University Irving Medical Center
New York, NY, USA
Dr. Sahil A. Parikh is the Director of Endovascular Services at Columbia University Medical Center and an Assistant Professor of Medicine at the Columbia University College of Physicians and Surgeons.
Dr. Parikh graduated magna cum laude from Harvard College with an AB in Biomedical Sciences and Engineering and went on to earn his MD from the Johns Hopkins University School of Medicine with Phi Beta Kappa and Alpha Omega Alpha honors. He completed his internal medicine residency and chief residency at Massachusetts General Hospital, cardiovascular medicine and interventional cardiology fellowships at Brigham and Women’s Hospital and vascular medicine and interventional fellowships at Massachusetts General Hospital, all teaching hospitals affiliated with Harvard Medical School. He is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Vascular Medicine and Endovascular Intervention.
Dr. Parikh’s clinical practice leverages his knowledge and experience in cardiovascular medicine and complex coronary and peripheral vascular interventions, with a focus on atherosclerotic vascular disease and intervention throughout the circulation. This includes coronary artery disease, PAD including claudication and CLI, renovascular disease, cerebrovascular disease, venous disease and thrombosis. He is a nationally recognized clinician educator and investigator in vascular medicine and intervention.
Dr. Parikh has won numerous teaching awards locally and co-directs several national educational programs for physicians in training and for continuing medical education in conjunction with the Cardiovascular Research Foundation (CRF), the American College of Cardiology (ACC) and the Society for Cardiac Angiography and Intervention (SCAI). His research interests focus on novel endovascular devices for the treatment of vascular disease. He has been the site and national principal investigator for several clinical trials and has authored more than 100 original manuscripts and reviews in basic and clinical cardiovascular medicine. He lectures frequently at national meetings including the Transcatheter Cardiovascular Therapeutics (TCT), ACC and SCAI.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Educational Awareness Solutions. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Educational Awareness Solutions. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.25 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
American Society of Radiologic Technologists
This activity has been reviewed and approved for 1.25 Category A CE credits by the ASRT.
European Board for Accreditation in Cardiology
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1.0 hour(s) of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Term of Offering
This activity was released on June 30, 2021 and is valid for one year. Requests for credit must be made no later than July 1, 2022.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the pre-activity questions, view the program in its entirety, and complete the post-activity questions, evaluation form, and credit request.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
|Reported Financial Relationship
Sahil A. Parikh, MD, FACC, FSCAI
|Consulting Fees: Abbott Vascular, Boston Scientific, Philips, CSI, Janssen, Medtronic, Abiomed, Terumo, Inari, Penumbra
Contracted Research: Abbott Vascular, Boston Scientific, Surmodics, Shockwave Medical, TriReme Medical
Erin H. Murphy, MD, FACS
|Consulting Fees: Medtronic, Philips, Boston Scientific, Cordis, Gore
Speaker’s Bureau: Philips, Medtronic
Advisory Board: Philips, Boston Scientific, Medtronic
The planners and managers have the following relevant financial relationships with ineligible companies:
Contracted Research: Vesper, Humacyte, Boston Scientific, PQ Bypass, Merit Medical, Medtronic, Intervene
Speaker’s Bureau: Philips, Cook Medical, Medtronic, Boston Scientific
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Educational Awareness Solutions do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
An Internet-connected web browser is required.